MedTrace Logo

Prophylactic Antibiotic Treatment in Hemodialysis

NCT05248620 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 800

Last updated 2024-01-30

No results posted yet for this study

Summary

The purpose of this study is to assess the efficacy of prophylactic antibiotic treatment on blood stream infections and severe culture negative infections, in patients on newly started hemodialysis(HD), with a central venous catheter as vascular access.

Conditions

  • Hemodialysis

Interventions

DRUG

Amoxicillin Clavulanic 500/125mg or placebo

Prophylactic antibiotic treatment

Sponsors & Collaborators

  • Zealand University Hospital

    lead OTHER

Principal Investigators

  • Niels E Bruun, Professor · Dept. cardiology, Zealand University Hospital, Roskilde, Denmark

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-14
Primary Completion
2028-10-31
Completion
2029-05-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05248620 on ClinicalTrials.gov